Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
45.36
+0.25 (0.55%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Supernus Pharmaceuticals Employees
Supernus Pharmaceuticals had 778 employees as of December 31, 2025. The number of employees increased by 104 or 15.43% compared to the previous year.
Employees
778
Change (1Y)
104
Growth (1Y)
15.43%
Revenue / Employee
$1,067,401
Profits / Employee
-$141,242
Market Cap
2.64B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 778 | 104 | 15.43% |
| Dec 31, 2024 | 674 | 22 | 3.37% |
| Dec 31, 2023 | 652 | 40 | 6.54% |
| Dec 31, 2022 | 612 | 37 | 6.43% |
| Jun 30, 2022 | 603 | - | - |
| Dec 31, 2021 | 575 | 12 | 2.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,100 |
| Trulieve Cannabis | 5,000 |
| HUTCHMED (China) | 1,790 |
| Alvotech | 1,279 |
| Prestige Consumer Healthcare | 890 |
| Indivior Pharmaceuticals | 838 |
| BioCryst Pharmaceuticals | 435 |
SUPN News
- 22 days ago - Supernus Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 22 days ago - Supernus Pharmaceuticals Earnings release: Q2 2026 - Filings
- 22 days ago - Supernus Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 22 days ago - Supernus Pharmaceuticals Slides: Q2 2026 - Filings
- 22 days ago - Supernus Pharmaceuticals Proxy statement: Proxy filing - Filings
- 22 days ago - Supernus Pharmaceuticals Proxy statement: Proxy filing - Filings
- 22 days ago - Supernus Pharmaceuticals Proxy statement: Proxy filing - Filings
- 22 days ago - Supernus, Indivior merge to strengthen neuroscience drug portfolio - Reuters